|
22 Jun 2020 |
50% Complete Response Rate Observed in YourVaccx™ Study for Patients with Metastatic Prostate Cancer was Presented at the AACR Virtual Annual Meeting II
|
|
20 Jun 2020 |
Clover Biopharmaceuticals Initiates Phase 1 Clinical Trial for COVID-19 Vaccine Candidate
|
|
18 Jun 2020 |
Codagenix Announces the Synthesis and Preliminary Safety of Scalable, Live-attenuated Vaccine Candidate Against COVID-19
|
|
18 Jun 2020 |
CureVac Receives Regulatory Approval from German and Belgian Authorities to Initiate Phase 1 Clinical Trial of its SARS-CoV-2 Vaccine Candidate
|
|
17 Jun 2020 |
HOOKIPA Announces FDA Clearance of its IND Application for HB-202/201 Clinical Trial to Treat HPV-Positive Cancers
|
|
17 Jun 2020 |
PDS Biotechnology and Farmacore Biotechnology Announce Co-Development of PDS0204 COVID-19 Vaccine
|
|
16 Jun 2020 |
Saiba AG Selects AGC Biologics to Develop and Produce COVID-19 Vaccine
|
|
16 Jun 2020 |
Immunomic Therapeutics Enters into License Agreement with Ichor Medical Systems to Use Electroporation (EP) Delivery Technology in Phase I Study of DNA Vaccine Therapy, ITI-1001
|
|
16 Jun 2020 |
Government-funded Imperial College COVID-19 vaccine moves into first human trials
|
|
15 Jun 2020 |
Catalent Signs Agreement with AstraZeneca to Manufacture COVID-19 Vaccine Candidate
|
|
15 Jun 2020 |
Treos Bio Forms New Subsidiary to Develop a Preventive COVID-19 Peptide Vaccine
|
|
15 Jun 2020 |
ATUM and Phylex BioSciences Collaborate to Accelerate the Development of a Universal SARS Coronavirus Vaccine
|
|
15 Jun 2020 |
Batavia Biosciences and Valneva Collaborate to Accelerate Development of Low-cost Inactivated Polio Vaccine
|
|
14 Jun 2020 |
AstraZeneca to supply Europe with up to 400 million doses of Oxford University’s vaccine at no profit
|
|
14 Jun 2020 |
Sinovac Announces Positive Preliminary Results of Phase I/II Clinical Trials for Inactivated Vaccine Candidate Against COVID-19
|
|
13 Jun 2020 |
Calquence showed long-term efficacy and tolerability for patients with chronic lymphocytic leukaemia in two trials
|
|
13 Jun 2020 |
FDA Approves Merck’s GARDASIL 9 for the Prevention of Certain HPV-Related Head and Neck Cancers
|
|
11 Jun 2020 |
Moderna Advances Late-Stage Development of its Vaccine (mRNA-1273) Against COVID-19
|
|
11 Jun 2020 |
Sinovac and Butantan Join Efforts to Advance the Clinical Development of An Inactivated Vaccine for COVID-19 to Phase III
|
|
11 Jun 2020 |
Catalent Partners with Spicona to Develop COVID-19 Vaccine Candidate using GPEx Cell Line Development Platform
|
|
10 Jun 2020 |
Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidate; Phase 1/2a Clinical Trial to Begin in Second Half of July
|
|
10 Jun 2020 |
Panacea Biotec and Refana Announce Landmark Collaboration for COVID-19 Vaccine
|
|
10 Jun 2020 |
UbiVac Announces Clinical Trial Collaboration with Bristol Myers Squibb on Combination Immunotherapy for Advanced Triple Negative Breast Cancer
|
|
08 Jun 2020 |
Bavarian Nordic Announces Topline Results from Phase 1 Clinical Trial of Equine Encephalitis Virus Vaccine
|
|
08 Jun 2020 |
The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
|
